Newsletter - December 2019

DHC Look Back Header - Year End Trends

FEATURED CONTENT: Year End Trends

As we close out 2019 and look forward to 2020, we are using this time to pause and take stock of how the DHC’s mission of engagement, education, and inspiration was realized in digital pharma marketing this year. We’ve asked DHC advisors and members to consider the industry’s successes in 2019 and what’s on the horizon for 2020.

This year, we have had the opportunity to facilitate the exchange of ideas, insights, and research on several key themes that we believe will see continued growth. Read the entire article →

ADDITIONAL INSIGHTS FROM DHC PARTNERS
Intouch - trends shaping pharma

What Matters Most: The Trends That Will Shape Pharma Marketing in 2020

Via Intouch Solutions →
As we began to look ahead to 2020, we sought out the opinions of the top people in our organization; we looked to our clients and around the industry; and we looked at the world of marketing, tech and healthcare overall. Several critical themes arose. In 2020, we believe that the most important trends won’t just be a new tool or channel. But at their core, these macro-trends we’re highlighting are about really looking at our customers and figuring out how our work can truly make a difference to them.

Read More →

The DHC in 2019 - A Look Back

Via DHC
An infographic look back at just a few of the many highlights over the last 12 months. Thank you to all of our members, Summit attendees, readers, and research partners for collaborating with us to drive engagement, education, and innovation.

See the Full Infographic →

DHC EVENTS COMING SOON
Future of data privacy

DHC Webinar

ITP - The Future of Data Privacy: The Impact & Why It Matters
Hosted by the DHC and Healthline

WHEN: January 29, 2020, noon eastern

Learn more →

DHC Summit

DHC Spring East Coast Summit
Hosted by Novartis

WHEN: April 2, 2020, 1pm - 5pm, followed by cocktails

Save the Date!

The DHC West Coast Summit wrapped up with an executive fireside chat with Gina Chapman, Vice President and U.S. head of Avastin, Herceptin, and Rituxan, Genentech and Mark Bard, Co-founder, DHC featuring an introspective discussion of the forces at play in pharma today. They celebrated the shift towards a more truly patient-centric environment and explored the ways in which personalized medicine will accelerate that move in the next 5 to 10 years.

Read more  →
SUBSCRIBE TO NEWSLETTER

Receive more DHC content like this directly in your inbox. We will respect your privacy and never sell your information.

View our Privacy Policy.

* indicates required
 
Would you like an invite to our next DHC event? Access to research?